Signals
Funding-only, explainable estimates from the data — not predictions, and not investment advice. Each score shows its base rate and the factors behind it.
Base rates (this dataset): a round is followed by another 37% of the time · 11.6% of companies with 2+ rounds have exited. · snapshot as of 2026-06-19
Methodology →Tech.eu Heat 50
Healthtech · top 50AllSoftwareHealthtechFintechMarketingTransportationMediaCleantechEnergyUKGermanyFranceSpainSwedenNetherlandsSwitzerlandIsrael
| # | Company | Stage | Last round | Timing | Raise next | Heat |
|---|---|---|---|---|---|---|
| 1 | Isomorphic Labs Healthtech · UK | Series B | 2026-05 | just raised · ▲ | 37 | 100 |
| 2 | Biorce Healthtech · Spain | Series A | 2026-02 | just raised · ▲ | 32 | 98 |
| 3 | FoRx Therapeutics Healthtech · Switzerland | Series A | 2025-12 | just raised · ▲ | 32 | 96 |
| 4 | Centauri Healthtech · UK | Series A | 2026-02 | just raised · ▲ | 32 | 94 |
| 5 | IMU Biosciences Healthtech · UK | Other | 2026-06 | just raised · ▲ | 21 | 93 |
| 6 | Aerska Healthtech · Ireland | Series A | 2026-02 | just raised · ▲ | 32 | 93 |
| 7 | Ingenix Healthtech · Poland | Seed | 2026-06 | just raised · ▲ | 31 | 92 |
| 8 | tacalyx Healthtech · Germany | Seed | 2026-04 | just raised · ▲ | 31 | 92 |
| 9 | Ona Therapeutics Healthtech · Spain | Series B | 2026-06 | just raised · ▲ | 34 | 91 |
| 10 | Recare Solutions Healthtech · Germany | Other | 2026-01 | just raised · ▲ | 21 | 91 |
| 11 | Oura Health Healthtech · Finland | Series D+ | 2025-10 | in window · ▲ | 65 | 88 |
| 12 | Tubulis Technologies Healthtech · Germany | Series C | 2025-10 | in window · ▲ | 62 | 88 |
| 13 | Uromems Healthtech · France | Growth/Late | 2026-05 | just raised · ▲ | 27 | 88 |
| 14 | Vitestro Healthtech · Netherlands | Series B | 2026-03 | just raised · ▲ | 34 | 87 |
| 15 | EnteroBiotix Healthtech · UK | Other | 2026-05 | just raised · ▲ | 23 | 87 |
| 16 | Owlstone Medical Healthtech · UK | Grant | 2025-10 | in window · ▲ | 57 | 86 |
| 17 | OpenUp Healthtech · Netherlands | Other | 2026-03 | just raised · ▲ | 21 | 86 |
| 18 | SamanTree Medical Healthtech · Switzerland | Other | 2026-01 | just raised · ▲ | 21 | 86 |
| 19 | Flinn Healthtech · Austria | Other | 2026-02 | just raised · ▲ | 21 | 85 |
| 20 | Alvotech Healthtech · Iceland | Debt | 2026-01 | in window · ▲ | 55 | 84 |
| 21 | Evaro Healthtech · UK | Series A | 2026-01 | just raised · ▲ | 32 | 84 |
| 22 | Exciva Healthtech · Germany | Series B | 2026-01 | just raised · ▲ | 34 | 83 |
| 23 | Hypervision Surgical Healthtech · UK | Series A | 2026-04 | just raised · ▲ | 32 | 83 |
| 24 | Generare Healthtech · France | Series A | 2026-04 | just raised · ▲ | 32 | 83 |
| 25 | nyra health Healthtech · Austria | Series A | 2026-02 | just raised · ▲ | 32 | 83 |
| 26 | Axmed Healthtech · Switzerland | Grant | 2026-02 | just raised · ▲ | 33 | 83 |
| 27 | Imperagen Healthtech · UK | Seed | 2026-05 | just raised · ▲ | 31 | 82 |
| 28 | Oviva Healthtech · UK | Series D+ | 2026-01 | just raised · ▲ | 38 | 81 |
| 29 | NVision Imaging Healthtech · Germany | Series B | 2026-05 | just raised · ▲ | 34 | 81 |
| 30 | Optics11 Healthtech · Netherlands | Debt | 2026-01 | in window · ▲ | 55 | 81 |
| 31 | Luminate Medical Healthtech · Ireland | Series A | 2026-01 | just raised · ▲ | 32 | 81 |
| 32 | AMSilk Healthtech · Germany | Other | 2025-09 | in window · ▲ | 37 | 80 |
| 33 | Lucis Healthtech · France | Series A | 2026-05 | just raised · ▲ | 32 | 80 |
| 34 | Tucuvi Healthtech · Spain | Series A | 2026-01 | just raised · ▲ | 32 | 80 |
| 35 | MyC Healthtech · France | Other | 2026-02 | just raised · ▲ | 21 | 80 |
| 36 | Bioliberty Healthtech · UK | Other | 2026-03 | just raised · ▲ | 23 | 80 |
| 37 | Anocca Healthtech · Sweden | Other | 2025-08 | in window · ▲ | 40 | 79 |
| 38 | Berlin Heals Holding Healthtech · Germany | Other | 2026-02 | just raised · ▲ | 23 | 79 |
| 39 | GlycanAge Healthtech · UK | Other | 2025-12 | just raised · ▲ | 21 | 79 |
| 40 | Avenue Biosciences Healthtech · Finland | Seed | 2026-01 | just raised · ▲ | 31 | 79 |
| 41 | Qida Healthtech · Spain | Other | 2025-11 | in window · ▲ | 37 | 78 |
| 42 | Xyall Healthtech · Netherlands | Other | 2026-02 | just raised · ▲ | 23 | 78 |
| 43 | Psyomics Healthtech · UK | Seed | 2025-10 | in window · ▲ | 59 | 78 |
| 44 | RAYDIAX Healthtech · Germany | Other | 2026-03 | just raised · ▲ | 21 | 78 |
| 45 | Gate2Brain Healthtech · Spain | Other | 2026-06 | just raised · ▲ | 23 | 78 |
| 46 | Leyden Labs Healthtech · Netherlands | Other | 2025-10 | in window · ▲ | 37 | 77 |
| 47 | NRG Therapeutics Healthtech · UK | Series B | 2025-09 | in window · ▲ | 59 | 77 |
| 48 | Storm Therapeutics Healthtech · UK | Series C | 2026-04 | just raised · ▲ | 40 | 77 |
| 49 | Phagos Healthtech · France | Series A | 2025-10 | in window · ▲ | 54 | 77 |
| 50 | Cellply Healthtech · Italy | Other | 2026-05 | just raised · ▲ | 21 | 77 |
Most likely to raise next
next-round likelihood- Tourlane71In typical raise window
- Framer71In typical raise window
- ŌURA71In typical raise window
- TechBBQ70In typical raise window
- Tines68In typical raise window
- This68In typical raise window
- Pactum68In typical raise window
- CarOnSale68In typical raise window
- Distribusion Technologies68In typical raise window
- WeTravel68In typical raise window
- BCAS67In typical raise window
- Oura Health65In typical raise window
Exit candidates
exit likelihood · 2+ rounds- Letgo314 rounds raised
- Factris286 rounds raised
- Pennylane287 rounds raised
- ManoMano288 rounds raised
- Pigment285 rounds raised
- Gett (GetTaxi)288 rounds raised
- Prophesee284 rounds raised
- Klarna2821 rounds raised
- Lightyear287 rounds raised
- Playtomic286 rounds raised
- N8N285 rounds raised
- Carbon Clean Solutions284 rounds raised
Scores are model estimates, not facts: a base rate computed from this dataset, adjusted by transparent funding-only factors (timing vs cohort gap, round-size momentum, backer re-investment, firm characteristics). No per-company “unicorn” probability is published. In a back-test (cut-off 30 June 2023, 18-month horizon), companies the model placed in their typical raise window went on to raise again about 1.8× as often as the average tracked company (~14% vs ~8%), while companies flagged dormant raised under 1% of the time. Estimates, not predictions.